Table 5 Frequency of non-fatal adverse events in included participants with AMI treated by primary PCI (n = 89)
|  | Group A ( n  = 44) | Group B ( n  = 45) | P value | ||
|---|---|---|---|---|---|
No | % | No | % | ||
Nonfatal MI | 0 | 0.0% | 0 | 0.0% | – |
Hospital admittance with HF | 5 | 11.4% | 8 | 17.8% | 0.392 |
Stent thrombosis | 0 | 0.0% | 0 | 0.0% | – |
CV death | 0 | 0.0% | 0 | 0.0% | – |